I agree that this site is using cookies. You can find further informations here.
X
Maur, Michela
58  results:
Search for persons X
?
1

First-in-human study of naporafenib (LXH254) with or withou..:

Janku, Filip ; Kim, Tae Min ; Iyer, Gopakumar...
European Journal of Cancer.  196 (2024)  - p. 113458 , 2024
Link: https://doi.org/10.1016/..
 
?
2

A phase Ib/II trial of capmatinib plus spartalizumab vs. sp..:

Santoro, Armando ; Assenat, Eric ; Yau, Thomas...
JHEP Reports.  6 (2024)  4 - p. 101021 , 2024
Link: https://doi.org/10.1016/..
 
?
3

A phase 2, multicenter, open-label study of anti-LAG-3 iera..:

Lin, Chia-Chi ; Garralda, Elena ; Schöffski, Patrick...
OncoImmunology.  13 (2023)  1 - p. , 2023
Link: https://doi.org/10.1080/..
 
?
4

A first-in-human phase 1/2 study of FGF401 and combination ..:

Chan, Stephen L. ; Schuler, Martin ; Kang, Yoon-Koo...
Journal of Experimental & Clinical Cancer Research.  41 (2022)  1 - p. , 2022
Link: https://doi.org/10.1186/..
 
?
5

Phase I/II study of the LAG-3 inhibitor ieramilimab (LAG525..:

Schöffski, Patrick ; Tan, Daniel S W ; Martín, Miguel...
Journal for ImmunoTherapy of Cancer.  10 (2022)  2 - p. e003776 , 2022
Link: https://doi.org/10.1136/..
 
?
6

Dissecting Tumor Growth: The Role of Cancer Stem Cells in D..:

Aramini, Beatrice ; Masciale, Valentina ; Grisendi, Giulia...
Cancers.  14 (2022)  4 - p. 976 , 2022
Link: https://doi.org/10.3390/..
 
?
7

Circulating and Intracellular miRNAs as Prognostic and Pred..:

Isca, Chrystel ; Piacentini, Federico ; Mastrolia, Ilenia...
Cancers.  13 (2021)  19 - p. 4894 , 2021
Link: https://doi.org/10.3390/..
 
?
8

Alpelisib in combination with everolimus ± exemestane in so..:

Curigliano, Giuseppe ; Martin, Miguel ; Jhaveri, Komal...
European Journal of Cancer.  151 (2021)  - p. 49-62 , 2021
Link: https://doi.org/10.1016/..
 
?
9

Deepening the Knowledge of ROS1 Rearrangements in Non-Small..:

Guaitoli, Giorgia ; Bertolini, Federica ; Bettelli, Stefania...
International Journal of Molecular Sciences.  22 (2021)  23 - p. 12867 , 2021
Link: https://doi.org/10.3390/..
 
?
10

Cancer treatment during the coronavirus disease 2019 pandem..:

Omarini, Claudia ; Maur, Michela ; Luppi, Gabriele...
European Journal of Cancer.  133 (2020)  - p. 29-32 , 2020
Link: https://doi.org/10.1016/..
 
?
11

Ceritinib plus Nivolumab in Patients with Advanced ALK-Rear..:

Felip, Enriqueta ; de Braud, Filippo G. ; Maur, Michela...
Journal of Thoracic Oncology.  15 (2020)  3 - p. 392-403 , 2020
Link: https://doi.org/10.1016/..
 
?
12

Treating cancer with immunotherapy in HIV-positive patients..:

Guaitoli, Giorgia ; Baldessari, Cinzia ; Maur, Michela...
Critical Reviews in Oncology/Hematology.  145 (2020)  - p. 102836 , 2020
Link: https://doi.org/10.1016/..
 
?
13

Everolimus (EVE) and exemestane (EXE) in patients with adva..:

Cazzaniga, Marina ; Verusio, Claudio ; Ciccarese, Mariangela...
Oncotarget.  9 (2018)  61 - p. 31877-31887 , 2018
Link: https://doi.org/10.18632..
 
?
14

Correction: Everolimus (EVE) and exemestane (EXE) in patien..:

Cazzaniga, Marina ; Verusio, Claudio ; Ciccarese, Mariangela...
Oncotarget.  9 (2018)  77 - p. 34639-34640 , 2018
Link: https://doi.org/10.18632..
 
?
15

Correction 2: Everolimus (EVE) and exemestane (EXE) in pati..:

Cazzaniga, Marina ; Verusio, Claudio ; Ciccarese, Mariangela...
Oncotarget.  9 (2018)  94 - p. 36720-36721 , 2018
Link: https://doi.org/10.18632..
 
1-15